New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 8, 2014
09:08 EDTZSPHZS Pharma receives notices of allowances from USPTO for ZS-9
ZS Pharma announced that it has received Notices of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Numbers 13/371,080 and 14/036,489 for ZS-9, the company’s product candidate in Phase 3 development for the treatment of hyperkalemia. The 13/371,080 Application describes compositions of matter that include ZS-9 and the 14/036,489 Application covers methods of treating hyperkalemia with compositions described in 13/371,080. The patents to be issued from these applications carry a patent term to at least 2032.
News For ZSPH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ZSPH

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use